CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Itraconazole Capsules +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04886323
NCT04886323N/ACompleted
CompareCT.gov

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis: a Randomized Controlled Trial

The Second Hospital of Anhui Medical University·interventional·Posted May 14, 2021·Updated Dec 26, 2023

In Brief

A clinical study evaluating Cold atmospheric plasma treatment device and Itraconazole Capsules for Malassezia Folliculitis. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalassezia Folliculitis
CountriesChina
CollaboratorsHefei CAS Ion Medical and Technical Devices Co.,Ltd

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 14, 2021
Enrollment StartAug 3, 2022
Primary CompletionDec 17, 2023
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.1 years ago

Interventions

Cold atmospheric plasma treatment devicedevice

Treat with cold atmospheric plasma treatment device.

Itraconazole Capsulesdrug

Treat with Itraconazole capsules